Commitments and Contingent Liabilities - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Lessee, Lease, Description [Line Items]
Operating lease, description	As of March 31, 2025, the Company leases office and laboratory space in Emeryville, California under operating leases which have terms through February 2027, and certain of these leases include options to extend for an additional 36 months. In addition to the base rent, which includes escalating payments over the lease term, the Company pays variable costs related to operating expenses and taxes, which are recognized as incurred. The Company also has multiple leases for laboratory equipment with terms of 36 months that are accounted for as finance leases. Total operating lease cost for the three months ended March 31, 2025 and 2024, was $0.9 million and $0.7 million, respectively. Total finance lease cost for each of the three months ended March 31, 2025 and 2024 was $0.3 million. Total variable lease cost for each of the three months ended March 31, 2025 and 2024 was $0.3 million. Total undiscounted lease obligations under the Company’s operating and finance leases were $6.9 million and $0.6 million, respectively, as of March 31, 2025.
Operating lease option to extend	options to extend for an additional 36 months.
Operating lease cost	$ 900,000	$ 700,000
Finance lease cost	300,000	300,000
Variable lease cost	300,000	$ 300,000
Undiscounted lease obligations, operating lease	6,900,000
Undiscounted lease obligations, finance lease	600,000
Accounts payable	8,472,000		$ 4,624,000
Accrued loss contingency	$ 0
Office and Laboratory
Lessee, Lease, Description [Line Items]
Operating lease term month and year	2027-02
Laboratory Equipment
Lessee, Lease, Description [Line Items]
Finance lease term of contract	36 months